2019
DOI: 10.1007/s11306-019-1613-3
|View full text |Cite
|
Sign up to set email alerts
|

Novel associations between blood metabolites and kidney function among Bogalusa Heart Study and Multi-Ethnic Study of Atherosclerosis participants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
15
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 15 publications
(17 citation statements)
references
References 54 publications
2
15
0
Order By: Relevance
“…The metabolites inversely associated with physical performance were all also associated with kidney function in our previous study in the BHS, with consistent effect direction [18]. These metabolites are presented in Supplementary Table 6, along with lookups of their associations with aging, inflammation, and mortality in previous research.…”
Section: Overlap With Kidney Function Metabolitessupporting
confidence: 67%
See 2 more Smart Citations
“…The metabolites inversely associated with physical performance were all also associated with kidney function in our previous study in the BHS, with consistent effect direction [18]. These metabolites are presented in Supplementary Table 6, along with lookups of their associations with aging, inflammation, and mortality in previous research.…”
Section: Overlap With Kidney Function Metabolitessupporting
confidence: 67%
“…Interestingly, all of the metabolites with inverse associations with physical performance measures were also inversely associated with kidney function in the BHS [18]. Many of these metabolites were also associated with kidney function in other populations [27,[34][35][36][37].…”
Section: Kidney Function and Agingmentioning
confidence: 90%
See 1 more Smart Citation
“…In these persons, concomitant consumption of bezafibrate may reduce oxidation (da Rosa-Junior et al 2020). As well, HMGA is largely metabolized in the kidney and excess plasma levels of HMGA may be an indicator of early-stage renal dysfunction (Nierenberg et al 2019) so again HMGA would not be appropriate for such individuals with an HMG-CoA lyase deficiency. Milajerdi et al (2020), in a review paper indicated that Atorvastatin and Simvistatin in T2D patients could decrease the generalized inflammatory marker (serum C-reactive protein, CRP) with Atorvastatin possibly reducing serum interleukin-6 (IL-6), the principal inducer of the CRP gene (Volanakis 2001).…”
Section: Pro-thrombosismentioning
confidence: 99%
“…Studies have shown increased levels of circulating metabolites in CKD [2][3][4] and association of metabolites with estimated glomerular filtration rate (eGFR). [5][6][7][8][9][10] Additional research has shown that some metabolites are extracted or released in the blood as part of intrarenal metabolism such as for renal gluconeogenesis and ammoniagenesis. 8,11 Therefore, kidney function is only one of the mechanisms accounting for circulating metabolites levels.…”
Section: Introductionmentioning
confidence: 99%